Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer.

Yachida S, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, Watanabe H, Masuda K, Nishimoto Y, Kubo M, Hosoda F, Rokutan H, Matsumoto M, Takamaru H, Yamada M, Matsuda T, Iwasaki M, Yamaji T, Yachida T, Soga T, Kurokawa K, Toyoda A, Ogura Y, Hayashi T, Hatakeyama M, Nakagama H, Saito Y, Fukuda S, Shibata T, Yamada T.

Nat Med. 2019 Jun;25(6):968-976. doi: 10.1038/s41591-019-0458-7. Epub 2019 Jun 6.

PMID:
31171880
2.

Initial and crucial genetic events in intestinal-type gastric intramucosal neoplasia.

Rokutan H, Abe H, Nakamura H, Ushiku T, Arakawa E, Hosoda F, Yachida S, Tsuji Y, Fujishiro M, Koike K, Totoki Y, Fukayama M, Shibata T.

J Pathol. 2019 Apr;247(4):494-504. doi: 10.1002/path.5208. Epub 2019 Jan 16.

PMID:
30474112
3.

Integrated genetic and epigenetic analysis of myxofibrosarcoma.

Ogura K, Hosoda F, Arai Y, Nakamura H, Hama N, Totoki Y, Yoshida A, Nagai M, Kato M, Arakawa E, Mukai W, Rokutan H, Kawai A, Tanaka S, Shibata T.

Nat Commun. 2018 Jul 17;9(1):2765. doi: 10.1038/s41467-018-03891-9.

4.

Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma.

Ohmoto A, Suzuki M, Takai E, Rokutan H, Fujiwara Y, Morizane C, Yanagihara K, Shibata T, Yachida S.

Oncotarget. 2018 Apr 20;9(30):21086-21099. doi: 10.18632/oncotarget.24930. eCollection 2018 Apr 20.

5.

Highly recurrent H3F3A mutations with additional epigenetic regulator alterations in giant cell tumor of bone.

Ogura K, Hosoda F, Nakamura H, Hama N, Totoki Y, Yoshida A, Ohashi S, Rokutan H, Takai E, Yachida S, Kawai A, Tanaka S, Shibata T.

Genes Chromosomes Cancer. 2017 Oct;56(10):711-718. doi: 10.1002/gcc.22469. Epub 2017 Jul 27.

PMID:
28545165
6.

Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.

Ohmoto A, Rokutan H, Yachida S.

Int J Mol Sci. 2017 Jan 13;18(1). pii: E143. doi: 10.3390/ijms18010143. Review.

7.

Comprehensive mutation profiling of mucinous gastric carcinoma.

Rokutan H, Hosoda F, Hama N, Nakamura H, Totoki Y, Furukawa E, Arakawa E, Ohashi S, Urushidate T, Satoh H, Shimizu H, Igarashi K, Yachida S, Katai H, Taniguchi H, Fukayama M, Shibata T.

J Pathol. 2016 Oct;240(2):137-48. doi: 10.1002/path.4761. Epub 2016 Sep 19.

PMID:
27313181
8.

NRF2 Intensifies Host Defense Systems to Prevent Lung Carcinogenesis, but After Tumor Initiation Accelerates Malignant Cell Growth.

Satoh H, Moriguchi T, Saigusa D, Baird L, Yu L, Rokutan H, Igarashi K, Ebina M, Shibata T, Yamamoto M.

Cancer Res. 2016 May 15;76(10):3088-96. doi: 10.1158/0008-5472.CAN-15-1584. Epub 2016 Mar 28.

9.

Heat Shock Protein 90 Is a Potential Therapeutic Target in Cholangiocarcinoma.

Shirota T, Ojima H, Hiraoka N, Shimada K, Rokutan H, Arai Y, Kanai Y, Miyagawa S, Shibata T.

Mol Cancer Ther. 2015 Sep;14(9):1985-93. doi: 10.1158/1535-7163.MCT-15-0069. Epub 2015 Jul 3.

10.

Time to Investigate the Gap between Symptomatic Response and Histologic/Immunohistochemical Parameters.

Rokutan H.

Clin Gastroenterol Hepatol. 2015 Sep;13(9):1701-2. doi: 10.1016/j.cgh.2015.02.001. Epub 2015 Feb 7. No abstract available.

PMID:
25668791
11.

Is sodium polystyrene sulfonate truly guilty without sorbitol?

Rokutan H.

Am J Med. 2014 Jul;127(7):e37. doi: 10.1016/j.amjmed.2013.11.029. No abstract available.

PMID:
24970612
12.

Mixed acinar-endocrine carcinoma of the pancreas treated with S-1.

Kanemasa Y, Kamisawa T, Tabata T, Kuruma S, Iwasaki S, Chiba K, Kuwata G, Fujiwara T, Egashira H, Koizumi K, Fujiwara J, Arakawa T, Momma K, Rokutan H, Horiguchi S, Hishima T.

Clin J Gastroenterol. 2013 Dec;6(6):459-64. doi: 10.1007/s12328-013-0416-8. Epub 2013 Sep 5.

PMID:
26182137
13.

Furosemide induces mortality in a rat model of chronic heart failure.

Rokutan H, Suckow C, von Haehling S, Strassburg S, Bockmeyer B, Doehner W, Waller C, Bauersachs J, von Websky K, Hocher B, Anker SD, Springer J.

Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29.

PMID:
21450356
14.

In vivo models of cardiac diseases: application to drug development and screening.

Rokutan H, Anker SD, Springer J.

Expert Opin Drug Discov. 2010 Jan;5(1):65-78. doi: 10.1517/17460440903460299.

PMID:
22823972

Supplemental Content

Loading ...
Support Center